Synthetic Biotechnology to Study and Engineer Ribosomal Bottromycin Biosynthesis

Dr Shwan Rachid and his co-author has published a new article in Chemistry & Biology, Volume 19, Issue 10, 1278-1287, 27 September 2012. The new publication covers Bottromycins which represent a promising class of antibiotics binding to the therapeutically unexploited A-site of the bacterial ribosome. The compounds inhibit bacterial translation process, and they are active against clinically important and multidrug resistant pathogens. In this work we set out to identify the biosynthetic gene locus in a terrestrial actinomycete, which is shown to produce bottromycin A2, B2, and C2. This work we identified the biosynthetic gene cluster required for bottromycin biosynthesis and set the stage for synthetic biotechnology approaches toward structure and yield improvement which is required for industrial large scale production.

Further details:

Synthetic Biotechnology to Study and Engineer Ribosomal Bottromycin Biosynthesis 

Liujie Huo, Shwan Rachid, Marc Stadler, Silke C. Wenzel, Rolf Müller

Chemistry & Biology - 26 October 2012 (Vol. 19, Issue 10, pp. 1278-1287)


Masters by a combination of research and coursework or by pure research in PhD level. (read more)

Knowledge Transfer is our main stream principal way to communicate in and outside our academic community (read more)

With 4 faculties and 25 departments in different fields we aiming to become a centre of excellence. Join us...